Your browser doesn't support javascript.
loading
A Genome Epidemiological Study of SARS-CoV-2 Introduction into Japan.
Sekizuka, Tsuyoshi; Itokawa, Kentaro; Hashino, Masanori; Kawano-Sugaya, Tetsuro; Tanaka, Rina; Yatsu, Koji; Ohnishi, Asami; Goto, Keiko; Tsukagoshi, Hiroyuki; Ehara, Hayato; Sadamasu, Kenji; Taira, Masakatsu; Shibata, Shinichiro; Nomoto, Ryohei; Hiroi, Satoshi; Toho, Miho; Shimada, Tomoe; Matsui, Tamano; Sunagawa, Tomimasa; Kamiya, Hajime; Yahata, Yuichiro; Yamagishi, Takuya; Suzuki, Motoi; Wakita, Takaji; Kuroda, Makoto.
Afiliación
  • Sekizuka T; Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Itokawa K; Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Hashino M; Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kawano-Sugaya T; Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Tanaka R; Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Yatsu K; Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Ohnishi A; Sapporo City Institute of Public Health, Sapporo, Japan.
  • Goto K; Ibaraki Prefectural Institute of Public Health, Ibaraki, Japan.
  • Tsukagoshi H; Gunma Prefectural Institute of Public Health and Environmental Sciences, Gunma, Japan.
  • Ehara H; Saitama Prefectural Institute of Public Health, Saitama, Japan.
  • Sadamasu K; Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
  • Taira M; Division of Virology and Medical Zoology, Chiba Prefectural Institute of Public Health, Chiba, Japan.
  • Shibata S; Microbiology Department, Nagoya City Public Health Research Institute, Aichi, Japan.
  • Nomoto R; Department of Infectious Diseases, Kobe Institute of Health, Kobe, Hyogo, Japan.
  • Hiroi S; Division of Microbiology, Osaka Institute of Public Health, Osaka, Japan.
  • Toho M; Fukui Prefectural Institute of Public Health and Environmental Science, Fukui, Japan.
  • Shimada T; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Matsui T; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Sunagawa T; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kamiya H; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Yahata Y; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Yamagishi T; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Suzuki M; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Wakita T; National Institute of Infectious Diseases, Tokyo, Japan.
  • Kuroda M; Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan makokuro@niid.go.jp.
mSphere ; 5(6)2020 11 11.
Article en En | MEDLINE | ID: mdl-33177213

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_pneumonia Asunto principal: Neumonía Viral / ARN Viral / Infecciones por Coronavirus / Betacoronavirus / Secuenciación Completa del Genoma Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: MSphere Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_pneumonia Asunto principal: Neumonía Viral / ARN Viral / Infecciones por Coronavirus / Betacoronavirus / Secuenciación Completa del Genoma Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: MSphere Año: 2020 Tipo del documento: Article País de afiliación: Japón
...